Australia is getting close to eliminating HIV transmission, but inequities in the delivery and uptake of prevention and treatment strategies remain.
For World AIDS Day, Curtis Chan from the Kirby Institute talks through the findings of the PrEP Appeal Study. The research found that cost and access are the main barriers to more people using pre-exposure prophylaxis, or PrEP.
Three academics from UNSW Sydney have been recognised for their outstanding contributions to injury research, treatments for HIV, viral hepatitis and COVID-19, and leadership in immunology.
We know from other viruses that viral fragments can remain in different tissues for months or even years. This could be the case for long COVID.
Increasing treatment access and reducing undiagnosed infections is vital for combating HIV, UNSW researchers have shown.
An international clinical trial has explored alternative approaches to second-line HIV therapy - with promising results.
As with all chronic conditions, a focus on cognitive and mental health should be part of ongoing care.
The sustained downward trend is likely due to high uptake of prevention measures, testing and high levels of treatment.
Lessons from the HIV epidemic should be applied to efficiently tackle the monkeypox outbreak and to avoid stigma.
Forty years after the first case of AIDS was described in the United States, the number of people diagnosed with HIV in Australia is at an all-time low.